Anesthesia for renal transplantation

J. W. Chapin, N. Bruda, S. Snider

Research output: Contribution to journalReview article

Abstract

Renal transplantation is the preferred mode of replacement therapy for most patients with end-stage renal disease (ESRD) and accounts for nearly 60% of all organ transplants in the United States. While as many as 35,000 people remain on the list waiting to receive a cadaveric kidney, living-related renal transplantation offers a shorter waiting period and greater survival. Maximization of the health of the kidney recipient before transplantation can improve ultimate outcome. Proper anesthetic management is facilitated by understanding the physiology and pharmacology of ESRD. Maintaining intraoperative blood volume is a key to good graft function, especially the living-related pediatric kidney recipient. Recent improvements in combined immunosuppression therapy have improved the overall outcome in transplant recipients. The average 3-year survival is nearly 75%.

Original languageEnglish (US)
Pages (from-to)106-113
Number of pages8
JournalSeminars in Cardiothoracic and Vascular Anesthesia
Volume2
Issue number2
DOIs
StatePublished - Jan 1 1998

Fingerprint

Kidney Transplantation
Anesthesia
Kidney
Chronic Kidney Failure
Transplants
Waiting Lists
Survival
Blood Volume
Immunosuppression
Anesthetics
Transplantation
Pharmacology
Pediatrics
Health
Therapeutics
Transplant Recipients

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Anesthesiology and Pain Medicine

Cite this

Anesthesia for renal transplantation. / Chapin, J. W.; Bruda, N.; Snider, S.

In: Seminars in Cardiothoracic and Vascular Anesthesia, Vol. 2, No. 2, 01.01.1998, p. 106-113.

Research output: Contribution to journalReview article

Chapin, J. W. ; Bruda, N. ; Snider, S. / Anesthesia for renal transplantation. In: Seminars in Cardiothoracic and Vascular Anesthesia. 1998 ; Vol. 2, No. 2. pp. 106-113.
@article{4146ad4aa95f48bbba3badb13acdf472,
title = "Anesthesia for renal transplantation",
abstract = "Renal transplantation is the preferred mode of replacement therapy for most patients with end-stage renal disease (ESRD) and accounts for nearly 60{\%} of all organ transplants in the United States. While as many as 35,000 people remain on the list waiting to receive a cadaveric kidney, living-related renal transplantation offers a shorter waiting period and greater survival. Maximization of the health of the kidney recipient before transplantation can improve ultimate outcome. Proper anesthetic management is facilitated by understanding the physiology and pharmacology of ESRD. Maintaining intraoperative blood volume is a key to good graft function, especially the living-related pediatric kidney recipient. Recent improvements in combined immunosuppression therapy have improved the overall outcome in transplant recipients. The average 3-year survival is nearly 75{\%}.",
author = "Chapin, {J. W.} and N. Bruda and S. Snider",
year = "1998",
month = "1",
day = "1",
doi = "10.1177/108925329800200203",
language = "English (US)",
volume = "2",
pages = "106--113",
journal = "Seminars in Cardiothoracic and Vascular Anesthesia",
issn = "1089-2532",
publisher = "SAGE Publications Inc.",
number = "2",

}

TY - JOUR

T1 - Anesthesia for renal transplantation

AU - Chapin, J. W.

AU - Bruda, N.

AU - Snider, S.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Renal transplantation is the preferred mode of replacement therapy for most patients with end-stage renal disease (ESRD) and accounts for nearly 60% of all organ transplants in the United States. While as many as 35,000 people remain on the list waiting to receive a cadaveric kidney, living-related renal transplantation offers a shorter waiting period and greater survival. Maximization of the health of the kidney recipient before transplantation can improve ultimate outcome. Proper anesthetic management is facilitated by understanding the physiology and pharmacology of ESRD. Maintaining intraoperative blood volume is a key to good graft function, especially the living-related pediatric kidney recipient. Recent improvements in combined immunosuppression therapy have improved the overall outcome in transplant recipients. The average 3-year survival is nearly 75%.

AB - Renal transplantation is the preferred mode of replacement therapy for most patients with end-stage renal disease (ESRD) and accounts for nearly 60% of all organ transplants in the United States. While as many as 35,000 people remain on the list waiting to receive a cadaveric kidney, living-related renal transplantation offers a shorter waiting period and greater survival. Maximization of the health of the kidney recipient before transplantation can improve ultimate outcome. Proper anesthetic management is facilitated by understanding the physiology and pharmacology of ESRD. Maintaining intraoperative blood volume is a key to good graft function, especially the living-related pediatric kidney recipient. Recent improvements in combined immunosuppression therapy have improved the overall outcome in transplant recipients. The average 3-year survival is nearly 75%.

UR - http://www.scopus.com/inward/record.url?scp=0031826616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031826616&partnerID=8YFLogxK

U2 - 10.1177/108925329800200203

DO - 10.1177/108925329800200203

M3 - Review article

AN - SCOPUS:0031826616

VL - 2

SP - 106

EP - 113

JO - Seminars in Cardiothoracic and Vascular Anesthesia

JF - Seminars in Cardiothoracic and Vascular Anesthesia

SN - 1089-2532

IS - 2

ER -